1. Home
  2. IMVT vs CENTA Comparison

IMVT vs CENTA Comparison

Compare IMVT & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • CENTA
  • Stock Information
  • Founded
  • IMVT N/A
  • CENTA 1955
  • Country
  • IMVT United States
  • CENTA United States
  • Employees
  • IMVT N/A
  • CENTA N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • CENTA Consumer Specialties
  • Sector
  • IMVT Health Care
  • CENTA Consumer Discretionary
  • Exchange
  • IMVT Nasdaq
  • CENTA Nasdaq
  • Market Cap
  • IMVT 2.5B
  • CENTA 2.1B
  • IPO Year
  • IMVT N/A
  • CENTA 1993
  • Fundamental
  • Price
  • IMVT $14.14
  • CENTA $30.52
  • Analyst Decision
  • IMVT Buy
  • CENTA Buy
  • Analyst Count
  • IMVT 10
  • CENTA 5
  • Target Price
  • IMVT $40.14
  • CENTA $40.25
  • AVG Volume (30 Days)
  • IMVT 1.4M
  • CENTA 323.9K
  • Earning Date
  • IMVT 05-28-2025
  • CENTA 05-07-2025
  • Dividend Yield
  • IMVT N/A
  • CENTA N/A
  • EPS Growth
  • IMVT N/A
  • CENTA N/A
  • EPS
  • IMVT N/A
  • CENTA 1.87
  • Revenue
  • IMVT N/A
  • CENTA $3,155,810,000.00
  • Revenue This Year
  • IMVT $108.88
  • CENTA $2.74
  • Revenue Next Year
  • IMVT N/A
  • CENTA $2.16
  • P/E Ratio
  • IMVT N/A
  • CENTA $16.38
  • Revenue Growth
  • IMVT N/A
  • CENTA N/A
  • 52 Week Low
  • IMVT $12.72
  • CENTA $27.70
  • 52 Week High
  • IMVT $34.47
  • CENTA $41.03
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 42.87
  • CENTA 47.39
  • Support Level
  • IMVT $13.36
  • CENTA $27.97
  • Resistance Level
  • IMVT $14.76
  • CENTA $31.12
  • Average True Range (ATR)
  • IMVT 0.89
  • CENTA 1.08
  • MACD
  • IMVT 0.05
  • CENTA 0.03
  • Stochastic Oscillator
  • IMVT 36.36
  • CENTA 69.67

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: